These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8018965)

  • 1. Prognostic value of a solubilized fraction of EGF receptors in primary breast cancer using an immunoenzymatic assay--a retrospective study.
    Spyratos F; Martin PM; Hacène K; Andrieu C; Romain S; Floiras JL; Magdelénat H
    Breast Cancer Res Treat; 1994 Jan; 29(1):85-95. PubMed ID: 8018965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: results of a 10 year follow-up study.
    Klijn JG; Look MP; Portengen H; Alexieva-Figusch J; van Putten WL; Foekens JA
    Breast Cancer Res Treat; 1994 Jan; 29(1):73-83. PubMed ID: 8018964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients.
    Osaki A; Toi M; Yamada H; Kawami H; Kuroi K; Toge T
    Am J Surg; 1992 Oct; 164(4):323-6. PubMed ID: 1357997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of epidermal growth factor receptor in a series of 303 breast cancers.
    Bolla M; Chedin M; Colonna M; Marron J; Rostaing-Puissant B; Chambaz E
    Eur J Cancer; 1992; 28A(6-7):1052-4. PubMed ID: 1627373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of cytosolic p53 protein in breast cancer.
    Montero S; Guzmán C; Vargas C; Ballestín C; Cortés-Funes H; Colomer R
    Tumour Biol; 2001; 22(5):337-44. PubMed ID: 11553865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of radioligand assay and immunostaining for epidermal growth factor receptor in human breast cancer.
    Hastrich DJ; Dunn JM; Nicholson S; Newcomb P; Farndon JR
    Br J Surg; 1994 Jun; 81(6):853-5. PubMed ID: 8044601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy.
    Nicholson RI; McClelland RA; Gee JM; Manning DL; Cannon P; Robertson JF; Ellis IO; Blamey RW
    Breast Cancer Res Treat; 1994 Jan; 29(1):117-25. PubMed ID: 7912565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptors in breast cancer: association with early relapse and death, poor response to hormones and interactions with neu.
    Harris AL; Nicholson S; Sainsbury JR; Farndon J; Wright C
    J Steroid Biochem; 1989; 34(1-6):123-31. PubMed ID: 2576295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-needle aspiration technique for the concurrent immunocytochemical evaluation of multiple biologic parameters in primary breast carcinoma.
    Bozzetti C; Nizzoli R; Naldi N; Manotti L; Savoldi L; Camisa R; Guazzi A; Cocconi G
    Breast Cancer Res Treat; 1994; 32(2):221-8. PubMed ID: 7865851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinoma.
    Gasparini G; Boracchi P; Bevilacqua P; Mezzetti M; Pozza F; Weidner N
    Breast Cancer Res Treat; 1994 Jan; 29(1):59-71. PubMed ID: 7912568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of c-erbB-2 protein in primary breast cancer tissue extract using an enzyme immunoassay.
    Watanabe T; Fukutomi T; Tsuda H; Adachi I; Nanasawa T; Yamamoto H; Abe K
    Jpn J Cancer Res; 1993 Dec; 84(12):1279-86. PubMed ID: 7904987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor angiogenesis in node-negative breast carcinomas--relationship with epidermal growth factor receptor, estrogen receptor, and survival.
    Fox SB; Leek RD; Smith K; Hollyer J; Greenall M; Harris AL
    Breast Cancer Res Treat; 1994 Jan; 29(1):109-16. PubMed ID: 7517221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer.
    Toi M; Nakamura T; Mukaida H; Wada T; Osaki A; Yamada H; Toge T; Niimoto M; Hattori T
    Cancer; 1990 May; 65(9):1980-4. PubMed ID: 2372767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients.
    Fox SB; Smith K; Hollyer J; Greenall M; Hastrich D; Harris AL
    Breast Cancer Res Treat; 1994 Jan; 29(1):41-9. PubMed ID: 8018963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor status, proliferating activity, and c-erbB2 oncoprotein. An immunocytochemical evaluation in breast cancer.
    Campani D; Sarnelli R; Fontanini G; Martini L; Cecchetti D; De Luca F; Squartini F
    Ann N Y Acad Sci; 1993 Nov; 698():167-73. PubMed ID: 7904137
    [No Abstract]   [Full Text] [Related]  

  • 16. Integration of estrogen and progesterone receptors with pathological and molecular prognostic factors in breast cancer patients.
    Gago FE; Tello OM; Diblasi AM; Ciocca DR
    J Steroid Biochem Mol Biol; 1998 Dec; 67(5-6):431-7. PubMed ID: 10030692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of cell kinetics in breast cancer.
    Amadori D; Volpi A; Callea A; Amaducci L; Morgagni S; Magni E; Nanni O
    Ann N Y Acad Sci; 1993 Nov; 698():186-92. PubMed ID: 8279756
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical parameters for prognostic evaluation in patients with breast cancer.
    Gion M; Mione R; Pappagallo GL; Gatti C; Nascimben O; Sampognaro E; Meo S
    Anticancer Res; 1994; 14(2B):693-8. PubMed ID: 8010728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell proliferation in 3,800 node-negative breast cancers: consistency over time of biological and clinical information provided by 3H-thymidine labelling index.
    Silvestrini R; Daidone MG; Luisi A; Mastore M; Leutner M; Salvadori B
    Int J Cancer; 1997 Feb; 74(1):122-7. PubMed ID: 9036880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-erbB-2 overexpression in primary breast cancer: independent prognostic factor in patients at high risk.
    Schönborn I; Zschiesche W; Spitzer E; Minguillon C; Möhner M; Ebeling K; Grosse R
    Breast Cancer Res Treat; 1994; 29(3):287-95. PubMed ID: 7914107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.